Fibronectin type III domain-containing protein 5 (FNDC5), a novel myokine secreted by contracting skeletal muscle, can attenuate inflammation and insulin resistance through AMPK-mediated macrophage polarization in HFD-induced obesity [18]. This evidence concerns the gene FNDC5 and obesity due to melanocortin 4 receptor deficiency.